Literature DB >> 29399500

A combination of transanal minimally invasive surgery and transanal technique to facilitate suturing during transanal minimally invasive surgery.

Robert Christie1,2, Jeremy Sugrue1,3, Saleh Eftaiha1,3, Jan Kaminski1, Tareq Kamal1, John Park1, Leela Prasad1,3, Slawomir Marecik1,3.   

Abstract

Transanal minimally invasive surgery (TAMIS) is an effective option for the local excision of benign, non-invasive rectal lesions, or selected early stage rectal cancers. However, the suturing encountered in TAMIS remains technically challenging. A combination of TAMIS and transanal approach to suturing is demonstrated to address this challenge. A 64-year-old female with a T1N0 adenocarcinoma located in the anterior mid-rectum underwent TAMIS for resection of the lesion. Total operative time was 91 minutes. Free peritoneal defect was closed in two layers. The patient was discharged on postoperative day 1. Final pathology revealed a 0.7 cm T1 well-differentiated adenocarcinoma 0.8 cm from the closest resection margin. The patient remains free of systemic or local recurrence at 24 months. TAMIS is a safe and effective option for removal of benign rectal lesions or selected low grade T1 adenocarcinomas of the rectum. A hybrid TAMIS and transanal approach to suturing may often easily address the technical challenge of pure laparoscopic suturing in TAMIS.

Entities:  

Keywords:  Transanal minimally invasive surgery (TAMIS); laparoscopy; suturing

Year:  2016        PMID: 29399500      PMCID: PMC5783273          DOI: 10.21037/jovs.2016.06.04

Source DB:  PubMed          Journal:  J Vis Surg        ISSN: 2221-2965


  12 in total

1.  Transanal minimally invasive surgery: a giant leap forward.

Authors:  Sam Atallah; Matthew Albert; Sergio Larach
Journal:  Surg Endosc       Date:  2010-02-21       Impact factor: 4.584

2.  Practice parameters for the management of rectal cancer (revised).

Authors:  J R T Monson; M R Weiser; W D Buie; G J Chang; J F Rafferty; W Donald Buie; Janice Rafferty
Journal:  Dis Colon Rectum       Date:  2013-05       Impact factor: 4.585

Review 3.  TransAnal Minimally Invasive Surgery (TAMIS) with SILS™ port versus Transanal Endoscopic Microsurgery (TEM): a comparative experimental study.

Authors:  Roberto Rimonda; Alberto Arezzo; Simone Arolfo; Alessandro Salvai; Mario Morino
Journal:  Surg Endosc       Date:  2013-05-01       Impact factor: 4.584

4.  Transanal Minimally Invasive Surgery: Review of Indications and Outcomes from 75 Consecutive Patients.

Authors:  Deborah S Keller; Reena N Tahilramani; Juan R Flores-Gonzalez; Ali Mahmood; Eric M Haas
Journal:  J Am Coll Surg       Date:  2016-02-13       Impact factor: 6.113

5.  Transanal employment of single access ports is feasible for rectal surgery.

Authors:  Renée M Barendse; Pascal G Doornebosch; Willem A Bemelman; Paul Fockens; Evelien Dekker; Eelco J R de Graaf
Journal:  Ann Surg       Date:  2012-12       Impact factor: 12.969

6.  Transanal excision vs. major surgery for T1 rectal cancer.

Authors:  Birger H Endreseth; Helge E Myrvold; Paal Romundstad; Unn E Hestvik; Tormod Bjerkeset; Arne Wibe
Journal:  Dis Colon Rectum       Date:  2005-07       Impact factor: 4.585

Review 7.  A critical review of the role of local excision in the treatment of early (T1 and T2) rectal tumors.

Authors:  Thomas A Heafner; Sean C Glasgow
Journal:  J Gastrointest Oncol       Date:  2014-10

8.  Transanal minimally invasive surgery for benign and malignant rectal neoplasia.

Authors:  Elisabeth C McLemore; Lynn A Weston; Alisa M Coker; Garth R Jacobsen; Mark A Talamini; Santiago Horgan; Sonia L Ramamoorthy
Journal:  Am J Surg       Date:  2014-04-01       Impact factor: 2.565

9.  Minimal invasive single-site surgery in colorectal procedures: Current state of the art.

Authors:  Michele Diana; Parag Dhumane; R A Cahill; N Mortensen; Joel Leroy; Jacques Marescaux
Journal:  J Minim Access Surg       Date:  2011-01       Impact factor: 1.407

10.  Transanal minimally invasive surgery: impact on quality of life and functional outcome.

Authors:  Maria Verseveld; Renée M Barendse; Martijn P Gosselink; Cornelis Verhoef; Eelco J R de Graaf; Pascal G Doornebosch
Journal:  Surg Endosc       Date:  2015-07-03       Impact factor: 4.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.